REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/06/2025
Back to search
Official data from USPTO
CUMBERLAND EMERGING TECHNOLOGIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CUMBERLAND EMERGING TECHNOLOGIES
ST13
US500000086827824Class
35, 36, 42
Filing
86827824
Registration
5035034
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
09/07/2025
Trademark type
Word
Nice classes
35, 36, 42
Filing date
11/20/2015
Registration date
09/06/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/13/2023
Last transaction
09/07/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
09/01/2000
First use in commerce
09/01/2000
Drawing code
4
Owner type
03
Owner location
Nashville, TN
Examiner
NELSON, EDWARD
Law office
L60
Current location
TMEG LAW OFFICE 106
Holders and representatives
Holders
Cumberland Pharmaceuticals Inc.
Representatives
Kristina Montanaro Schrader Adams and Reese LLP
Technical classification
Nice Classes
Class 35Class 36Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business supportconsultingmanagement in the field of clinical trialsclinical data and regulatory submission management on behalf of individuals and companies to assist them with clinical researchclinical trials and applications for approval of pharmaceuticals and biomedical technologies; Advertisingmarketing and promotion services; Administration and management of research grants
Class 36
Leasing of office space
Class 42
Development and research services in the fields of biomedical technologies and pharmaceuticals; Conducting research and clinical trials for others in the fields of biomedical technologies and pharmaceuticals; Consulting services in the fields of biomedical technologies and pharmaceuticals; Rental of laboratory apparatus and instruments; Leasing of laboratories containing laboratory equipment for scientific research and development of biomedical technologies and pharmaceuticals
Publications
History of USPTO decisions and trademark events.
33 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/13/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/13/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/13/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/16/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/16/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/16/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/16/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/16/2023
E815
TEAS SECTION 8 & 15 RECEIVED
07/28/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/22/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/22/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/22/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/21/2016
PUBO
PUBLISHED FOR OPPOSITION
06/21/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/01/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/16/2016
ALIE
ASSIGNED TO LIE
05/09/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/20/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/20/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/20/2016
DMCC
DATA MODIFICATION COMPLETED
04/06/2016
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
03/17/2016
ALIE
ASSIGNED TO LIE
03/17/2016
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/17/2016
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/17/2016
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
03/17/2016
DOCK
ASSIGNED TO EXAMINER
03/14/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/25/2015
NWAP
NEW APPLICATION ENTERED
11/24/2015
Continuous trademark protection
Get notified about every new filing that threatens CUMBERLAND EMERGING TECHNOLOGIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.